Opportunity Information: Apply for RFA CK 14 00504CONT17
This opportunity is a continuation cooperative agreement from the Centers for Disease Control and Prevention (CDC) focused on a Creutzfeldt-Jakob Disease (CJD) lookback study, specifically aimed at assessing the risk of blood-borne transmission of the classic forms of CJD. In practical terms, the grant supports ongoing public health work that traces back potential exposure pathways involving blood and blood products, with the goal of better understanding whether and how classic CJD might be transmitted through transfusion or related blood-derived routes. Because CJD is a rare but fatal neurodegenerative prion disease, even a low-probability transmission risk has serious implications for blood safety policy, donor screening practices, and surveillance strategies. The emphasis on a "lookback" design signals that the work involves retrospective investigation, typically linking diagnosed CJD cases to prior donation or transfusion histories, then following the chain of potentially exposed recipients or donors to evaluate outcomes and identify any evidence consistent with transmission.
The funding mechanism is a cooperative agreement, which generally means CDC expects to be substantially involved in the funded activities rather than acting only as a pass-through funder. Cooperative agreements often involve collaboration on study design refinements, data elements, case definitions, analytic approaches, and coordination with national surveillance or laboratory resources. The activity category is Health, and the listing references CFDA number 93.084, which corresponds to CDC public health programs and underscores that this is fundamentally a public health surveillance and risk assessment effort rather than a purely academic research grant. The opportunity is labeled as continuation funding, reinforcing that it is meant to sustain an existing project or network rather than establish a new, open competition for first-time applicants.
Eligibility is narrowly restricted: only organizations that were previously awarded funding under the original announcement, RFA-CK-14-005, are eligible to receive this continuation award. That restriction is explicit and central to the notice. It means new applicants who were not part of the prior award cohort cannot apply, and the continuation is intended to maintain momentum, preserve specialized expertise, and ensure continuity of long-running follow-up that can be essential for rare disease investigations. The expected number of awards is listed as 10, indicating CDC anticipated supporting up to ten continuing entities under this continuation action, likely reflecting the number of prior recipients or the structure of the existing multi-site effort.
Key administrative details include the funding opportunity number RFA CK 14 00504CONT17, which indicates it is a continuation associated with the 2014 CJD lookback initiative, with the continuation notice posted in 2017. The original closing date for this continuation action is April 14, 2017, and the creation date is February 8, 2017. The award ceiling is listed as 0, which typically signals that a specific cap was not provided in the public synopsis or that the ceiling is determined through other budget guidance tied to the continuation awards rather than a standard competitive maximum. The sponsoring agency is the Centers for Disease Control and Prevention, listed through CDC - ERA (reflecting the electronic research administration system used for submissions and grants management).
Overall, the opportunity is best understood as a targeted continuation of an established CDC-supported CJD blood safety evaluation effort. Its purpose is to continue collecting and analyzing data needed to clarify the real-world risk, if any, of blood-borne transmission for classic CJD forms, using lookback methods and coordinated public health collaboration. The restricted eligibility and continuation structure indicate the primary goal is to sustain an existing, specialized set of partners and workflows rather than launch a new research program.Apply for RFA CK 14 00504CONT17
- The Centers for Disease Control and Prevention - ERA in the health sector is offering a public funding opportunity titled "Centers for Disease Control and Prevention a Creutzfeldt-Jakob Disease (CJD) Lookback Study: Assessing the Risk Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.084.
- This funding opportunity was created on 2017-02-08.
- Applicants must submit their applications by 2017-04-14. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 10 candidate(s).
- Eligible applicants include: Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is this funding opportunity about?
This is a CDC continuation cooperative agreement supporting a Creutzfeldt-Jakob Disease (CJD) lookback study. The work focuses on assessing the risk of blood-borne transmission of the classic forms of CJD, using retrospective (lookback) investigations that connect diagnosed CJD cases with prior donation or transfusion histories and then follow potential exposure pathways.
What is the main goal of the CJD lookback study described here?
The goal is to continue collecting and analyzing information that helps clarify whether, and under what circumstances, classic CJD might be transmitted through blood, blood products, transfusions, or related blood-derived routes. Because CJD is rare but fatal, even a low-probability risk can matter for blood safety policy and public health decision-making.
What does "lookback" mean in this context?
A lookback design is a retrospective investigation. In practical terms, it typically involves linking diagnosed CJD cases to past donation or transfusion histories, then tracing and following the chain of potentially exposed recipients or donors to evaluate outcomes and look for evidence consistent with transmission.
Why is CDC supporting this work if CJD is rare?
CJD is described as a rare but fatal neurodegenerative prion disease. The public health concern is that even a small or uncertain risk of transmission through blood could have serious implications for blood safety policy, donor screening practices, and surveillance strategies.
Is this a research grant or a public health surveillance effort?
Based on the description and the Health activity category, this is best understood as a public health surveillance and risk assessment effort supported through CDC. It is tied to CFDA 93.084, which is associated with CDC public health programs, and the work emphasizes coordinated investigation and ongoing data collection rather than launching a new academic research program.
What type of funding mechanism is being used?
The mechanism is a cooperative agreement. That generally means CDC expects to be substantially involved in the funded activities, rather than acting only as a pass-through funder.
What does CDC involvement typically look like under a cooperative agreement?
The notice indicates CDC collaboration may include study design refinements, agreement on data elements, case definitions, analytic approaches, and coordination with national surveillance or laboratory resources. In other words, CDC is expected to work closely with awardees on how the effort is carried out.
Is this opportunity open to new applicants?
No. Eligibility is explicitly restricted to organizations that were previously awarded funding under the original announcement RFA-CK-14-005. Organizations that were not part of the prior award cohort are not eligible for this continuation award.
What does it mean that this is "continuation" funding?
It means the funding is intended to sustain an existing CDC-supported project or network rather than create a new, open competition. The purpose is to maintain continuity, preserve specialized expertise, and support the long-running follow-up that can be important in rare disease investigations like CJD.
How many awards does CDC expect to make?
The expected number of awards is listed as 10, which suggests CDC anticipated supporting up to ten continuing entities under this continuation action.
What is the funding opportunity number for this announcement?
The funding opportunity number is RFA CK 14 00504CONT17.
How does this opportunity relate to the earlier CJD lookback initiative?
The opportunity number indicates it is a continuation associated with the 2014 CJD lookback initiative (RFA-CK-14-005). The continuation notice is described as being posted in 2017.
Who is the sponsoring agency?
The sponsoring agency is the Centers for Disease Control and Prevention (CDC), and it is listed through CDC - ERA, reflecting the electronic research administration system used for submissions and grants management.
What CFDA number is referenced, and what does it signal?
The listing references CFDA 93.084. In the context provided, that reference reinforces that the work aligns with CDC public health programs and that the effort is fundamentally a public health surveillance and risk assessment activity.
What are the key dates listed for this continuation action?
The creation date is February 8, 2017, and the original closing date is April 14, 2017.
What does it mean that the award ceiling is listed as 0?
The award ceiling is listed as 0, which typically indicates that a specific maximum cap was not provided in the public synopsis or that the ceiling is determined through other budget guidance tied to the continuation awards rather than a standard competitive maximum.
What specific form of CJD is emphasized in this work?
The focus is on the classic forms of CJD, with the study aimed at assessing the risk of blood-borne transmission for those classic forms.
What kinds of public health decisions could this work inform?
The description highlights implications for blood safety policy, donor screening practices, and surveillance strategies, particularly because the work is designed to clarify real-world transmission risk (if any) using lookback methods.
What is the overall purpose of continuing this effort?
Overall, the continuation is intended to sustain an established CDC-supported CJD blood safety evaluation effort, continuing coordinated data collection and analysis to better understand whether blood-borne transmission occurs for classic CJD and to support public health collaboration around that question.
Browse more opportunities from the same category: Health
Next opportunity: Cooperative Agreement to Support the Joint Institute for Food Safety and Applied Nutrition, JIFSAN (U19)
Previous opportunity: TIME-VARYING NUCLEAR DECAY PARAMETERS
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CK 14 00504CONT17
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CK 14 00504CONT17) also looked into and applied for these:
| Funding Opportunity |
|---|
| Centers for Disease Control and Prevention US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations Apply for RFA IP 15 00203CONT17 Funding Number: RFA IP 15 00203CONT17 Agency: Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: Case Dependent |
| CDC-Mexico Cooperative Agreement for Surveillance, Epidemiology, and Laboratory Capacity Apply for CDC RFA CK17 1707 Funding Number: CDC RFA CK17 1707 Agency: Centers for Disease Control - NCEZID Category: Health Funding Amount: Case Dependent |
| Building Capacity of the Public Health System to Improve Population Health through National, Nonprofit Organizations Apply for CDC RFA OT13 13020401SUPP17 Funding Number: CDC RFA OT13 13020401SUPP17 Agency: Centers for Disease Control - OSTLTS Category: Health Funding Amount: $914,757 |
| Strengthening the Public Health System in the U.S.-Affiliated Pacific Islands Apply for CDC RFA OT16 16010101SUPP17 Funding Number: CDC RFA OT16 16010101SUPP17 Agency: Centers for Disease Control - OSTLTS Category: Health Funding Amount: $150,000 |
| Increasing Public Awareness and Provider Education About Primary Immunodeficiency Disease Apply for CDC RFA OE17 1702 Funding Number: CDC RFA OE17 1702 Agency: Centers for Disease Control - CSELS Category: Health Funding Amount: $921,500 |
| Centers for Disease Control and Prevention Collaboration on Climate Sensitive Diseases and Health Effects Solicitation for FY2014 Noncompetitive Continuation Application Apply for RFA CK 14 00304CONT17 Funding Number: RFA CK 14 00304CONT17 Agency: Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: Case Dependent |
| Conducting Public Health Research in China Apply for RFA GH 17 005 Funding Number: RFA GH 17 005 Agency: Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $5,000,000 |
| Cambodia Health Quality Activity Apply for RFI 442 17 000002 Funding Number: RFI 442 17 000002 Agency: Cambodia USAID-Phnom Penh Category: Health Funding Amount: $24,990,000 |
| Public Health Systems Capacity Building in India Department of Health and Human Services Centers for Disease Control and Prevention Apply for CDC RFA GH14 141604CONT17 Funding Number: CDC RFA GH14 141604CONT17 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Strengthening of Public Health Programs to address Communicable and Non-Communicable Diseases in the Republic of Kenya. Apply for CDC RFA GH16 170302CONT17 Funding Number: CDC RFA GH16 170302CONT17 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Enhancing national STD/HIV prevention efforts by promoting holistic, comprehensive, and evidence-informed health and wellness approaches through strategic partnerships Apply for CDC RFA PS17 1708 Funding Number: CDC RFA PS17 1708 Agency: Centers for Disease Control - NCHHSTP Category: Health Funding Amount: Case Dependent |
| Lead Poisoning Prevention- Childhood Lead Poisoning Prevention---financed partially by Prevention and Public Health Funds Apply for CDC RFA EH17 1701PPHF17 Funding Number: CDC RFA EH17 1701PPHF17 Agency: Centers for Disease Control - NCEH Category: Health Funding Amount: $445,000 |
| Healthy Lifestyles in Youth Project Apply for HHS 2017 IHS HLY 0001 Funding Number: HHS 2017 IHS HLY 0001 Agency: Indian Health Service Category: Health Funding Amount: $1,250,000 |
| Noncommunicable Disease Prevention and Health Promotion in the Region of the Americas, PAHO Department of Health and Human Services Centers for Disease Control and Prevention Apply for CDC RFA GH15 161803CONT17 Funding Number: CDC RFA GH15 161803CONT17 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Building Capacity of the Public Health System to Improve Population Health through National, Nonprofit Organizations, financed in part by 2017 Prevention and Public Health Funds Apply for CDC RFA OT13 13020502SUPP17 Funding Number: CDC RFA OT13 13020502SUPP17 Agency: Centers for Disease Control - OSTLTS Category: Health Funding Amount: $3,000,000 |
| Increasing Newborn Screening Laboratory Capability to Detect Severe Combined Immunodeficiency (SCID) Using Next Generation Sequencing Technologies Apply for CDC RFA EH17 1703 Funding Number: CDC RFA EH17 1703 Agency: Centers for Disease Control - NCEH Category: Health Funding Amount: $150,000 |
| Addressing Ebola and other Highly Infectious Diseases Internationally Apply for CDC RFA CK15 150505SUPP17 Funding Number: CDC RFA CK15 150505SUPP17 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Implementing Technical and Science Support Services (TSSS) in the Republic of Rwanda under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 157004CONT17 Funding Number: CDC RFA GH15 157004CONT17 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Strengthening Implementation and Use of Effective Health Information Systems through Improved Governance, Design, Planning, Capacity Development, and Technical Implementation under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH18 1840 Funding Number: CDC RFA GH18 1840 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $10,000,000 |
| Technical Assistance Services to Improve the Control and Prevention Efforts of Tuberculosis (TB) under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH18 1837 Funding Number: CDC RFA GH18 1837 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $250,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CK 14 00504CONT17", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.